text:
Women's Health Innovation Summit
Strengthening the Women's Healthcare network, boosting investments & accelerating innovation
Download 2020 Agenda
VIRTUAL SUMMIT | PDT Timezone
14-15 September, 2021
Don't miss the first in the 2021 Women's Health Innovation Series: The Contraception Innovation Summit., taking place February 23 2021. The Contraception Summit is about putting women at the centre of contraceptive research, innovations, and education to improve women's contraceptive journeys throughout their lives. Join our leading network of pharma, biotech, medical device companies, start-ups, investors, researchers, and HCPs to drive innovation at the convergence of healthcare and technology.
View the full video
Women's health today is under-served from an innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl. investors and insurers). It is imperative to develop the eco-system, shift mindsets and embrace the holistic women-centred approach.
The Women's Health Innovation Summit (WHI) is THE forum for pharmaceutical and medical devices companies, start-ups and investors, doctors, researchers and HCPs, employers and insurers to drive innovation at the convergence of healthcare and technology.
We tackle the female prevalent verticals (e.g. contraception, pregnancy, breast cancer, and fertility), as well as other verticals including cardiovascular diseases, inconsistency, diabetes, mental health, sexual health amongst others.
This event is for strengthening and advancing research, investments and partnerships to ultimately improve the access and quality of healthcare for women worldwide.
To make the difference and to move your business forward, join us!
Industry Leading Speakers
Dedicated Networking Hours
don't miss the 1st in the WHI 2021 Series: Contraception Innovation Summit
The Contraception Innovation Summit, is the first of a series of discussions taking place in early 2021 as part of the wider Women's Health Innovation Series.
Joining us are lead innovators and thought leaders committed to our mission of accelerating innovation, education, and investment to improve access to and quality of women's contraception journeys.
Our inspiring speaker line-up includes, The Bill & Melinda Gates Foundation, Cooper Surgical, Dare Bioscience, Agile Therapeutics, Rhia Ventures and a lot more.
WHI Steering Committee 2021
Maryjane Lacoste
Senior Program Officer for Family Planning Service Delivery and Quality
Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality. As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring. She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies. Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi. She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.
Alice Zheng, MD, MBA, MPH
Women's Health Practice Leader
Susan C. Nicholson, MD, FIDSA
Vice President, Women's Health
Dr. Stephen Gerrard Ph.D.
Independent Expert Advisor Contraception R&D
Jarrad Aguirre
Head of Corporate Strategy and Advocacy
Myovant Sciences
Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee.
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health.
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.
Save the date: Women's Health Innovation Series
10 Highlights of WHIS 2021:
1. Understand the barriers to success and innovation in women's health, and how to overcome them.
2. How Tech and Healthcare can collaborate to scale health solutions in unprecedented way.
3. Breakthrough Innovations:
Investors: Identify your next acquisition target/opportunity. Meet the top innovators across therapies, digital innovations/telehealth, devices, AI and wearables.
Emerging Brands: Showcase your innovations, gain exposure to the wider universe of investors/partners.
4. Discover Unmet Needs: Deepen your understanding and hear from leading doctors, clinicians & heads of women's health in hospitals.
5. Provide a holistic women-centred approach to healthcare that goes beyond treatment. Learn more about customers' preferences, advertising regulations and marketing strategies.
6. Finance & Investments: Learn financial and investors' strategies in the field and an in-depth look at what they are looking for in Women's Health.
7. Address the needs of women across the generational gap and speaking to them in a language that resonates through personalized customer interactions
8. Developing Eco-system: meet all the stakeholders to strengthen the women's health network and accelerate solutions for your commercial success
9. Focus on Diseases & Issues: gain actionable intelligence on innovations in contraception, fertility, vaginal health and microbiome, pregnancy care and delivery, breast cancer treatment and rehabilitation, abortion, menopause and menstrual cycle, mental health, inconsistency disorders, urogynaecology, diabetes, maternal and sexual health.
10. Studies, Clinical Validation & Hospital Partnerships: Hear from leading organisations organising inclusive studies, working with data successfully and pushing the barriers in advancing women's health.
Pharma/Biotech/Digital Health/Med Device/Diagnostics
Payors/Insurers/Employers
+ Join Us
Daré Bioscience
Al Altomari
Agile Therapeutics
Mr. Altomari has served as our Chairman of the board and Chief Executive Officer since October 2016 and has been a member of our board of directors since February 2004. Mr. Altomari served as President and Chief Executive Officer from 2010 to 2016. Previously Mr. Altomari served as Agile's Executive Chairman from 2004 to 2010. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer.
Mr. Altomari has served as our Chairman of the board and Chief Executive Officer since October 2016 and has been a member of our board of directors since February 2004. Mr. Altomari served as President and Chief Executive Officer from 2010 to 2016. Previously Mr. Altomari served as Agile's Executive Chairman from 2004 to 2010. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer. In 2008, in his role as Chief Executive Officer and as a member of Barrier's board of directors, Mr. Altomari completed the successful sale of Barrier to Stiefel Laboratories, which was subsequently acquired by GlaxoSmithKline plc. From 1982 to 2003, Mr. Altomari held numerous executive roles in general management, commercial operations, business development, product launch preparation, and finance with Johnson & Johnson. Mr. Altomari also serves on the board of directors of Insmed Inc. and Baudax Bio, Inc. He previously served on the board of directors of Recro Pharm, Inc. Mr. Altomari received an M.B.A. from Rider University and his B.S. from Drexel University. He currently serves on the LeBow College of Business Advisory Board and the Board of the Charles D. Close School of Entrepreneurship at Drexel University. He currently is a member of the Board of Directors for TASK (Trenton Area Soup Kitchen).
David Portman
Founder, CEO and Medical Director
Sermonix Pharmaceuticals
Founder, CEO and Medical Director of Sermonix Pharmaceuticals.
Director Emeritus of a Clinical Research Center with research interests in menopause, sexual dysfunction, hormone replacement therapy, SERMs, osteoporosis, contraception and gynecologic endocrinology. Conducted over 140 clinical trials in women's health.
Lectures nationally, internationally and consults widely on women's health issues, and is on numerous advisory boards. Board-certified Obstetrician/Gynecologist.
Angie Kalousek Ebrahimi
Executive Director, Mind-Body Medicine
Angie Kalousek Ebrahimi oversees the sales and marketing of clinically proven lifestyle medicine programs for Blue Shield of California's members. Angie and her team work to drive both enrollment and engagement in the lifestyle medicine interventions under the Wellvolution brand. Angie strongly believes that lifestyle medicine can transform the current health care model by introducing clinically effective, cost effective and non-invasive lifestyle approaches into the care continuum.
Angie Kalousek Ebrahimi oversees the sales and marketing of clinically proven lifestyle medicine programs for Blue Shield of California's members. Angie and her team work to drive both enrollment and engagement in the lifestyle medicine interventions under the Wellvolution brand. Angie strongly believes that lifestyle medicine can transform the current health care model by introducing clinically effective, cost effective and non-invasive lifestyle approaches into the care continuum. She, herself, has incorporated lifestyle medicine into her own life to prevent disease and live in optimal health. Angie is strategically working to forward Blue Shield of California's philosophy that lifestyle is medicine.
Prior to joining Blue Shield in 2010, Angie worked as the Wellness Program Manager at Visa, Inc. where she created and implemented a new suite of global wellness programs for Visa employees. Part of her role at Visa was to incorporate Visa wellness programming with health plan offerings so that employees had a seamless experience. Prior to her time at Visa, Angie served as the Fitness Director at the Sports Club LA in San Francisco where she oversaw a staff of 60 trainers, nutritionists, and sports coordinators. In her role there, she also managed new member fitness programs, trainer education and direct private training sales. Angie has also worked in marketing, business planning and accounting.
Angie holds an MBA from Golden Gate University, a BS in Business from the University of California, Haas School of Business, Berkeley, and is a Certified Holistic Lifestyle Coach.
Nelson Ambrogio
Senior Vice President and General Manager Women's Healthcare
Bayer Pharmaceuticals US
Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people's lives.
As the leader of the Bayer Women's Healthcare team, he is responsible for Bayer's leading contraceptive portfolio, with revenues in excess of 900m$ and leading a cross-functional organization of more than 300 team members.
In his previous role, Nelson led the Bayer Pharmaceuticals team in Australia and New Zealand, where he was responsible for the launch of blockbuster drugs including Xarelto (cardiovascular) and Eylea (ophthalmology) and guiding a team of more than 250 people.
Nelson's career spans more than 20 years with Bayer and Schering in both mature and emerging markets across Latin America, Europe and Australasia. He has held the position of managing director of Bayer Portugal, business unit director General Medicine, Bayer Brazil and assistant to a Bayer Board Member at the company's headquarters in Germany.
Nelson started his career at Schering in his native Uruguay and was instrumental in the program management of the Bayer-Schering integration in Latin America and Canada.
Lynn Seely MD
Lynn Seely, MD, is the Chief Executive Officer of Myovant Sciences, a healthcare company focused on developing innovative treatments for women's health and prostate cancer. Dr. Seely is an endocrinologist with over 20 years of drug development and executive leadership experience. Prior to Myovant, she served as Chief Medical Officer at Medivation from 2005-2015 and led the development of XTANDI® (enzalutamide) for the treatment of metastatic castration-resistant prostate cancer from IND-enabling studies through to NDA approval and post-approval clinical studies.
Dr. Seely currently serves on the Board of Directors of Blueprint Medicines Corporation. She completed her residency in internal medicine at Yale-New Haven Hospital and a basic science and clinical fellowship in endocrinology and metabolism at the University of California, San Diego.
Luba Greenwood
Co-Founder & Board Member, Former Strategic BD & Corporate Ventures at Verily
Andrea S. Lukes, MD, MHSc, FACOG
Dr. Andrea S. Lukes is a board-certified OB/GYN, a Fellow of The American Congress of Obstetricians and Gynecologists and an expert on clinical development of women's health products across a wide range of indications across the female lifecycle. Her areas of expertise include but are not limited to endometrial ablation, endometriosis, hysteroscopy, minimally invasive gynecology, bleeding disorders, uterine fibroids, contraception, menopause and vasomotor symptoms, hereditary cancer screening and prenatal counseling. Dr.
Dr. Andrea S. Lukes is a board-certified OB/GYN, a Fellow of The American Congress of Obstetricians and Gynecologists and an expert on clinical development of women's health products across a wide range of indications across the female lifecycle. Her areas of expertise include but are not limited to endometrial ablation, endometriosis, hysteroscopy, minimally invasive gynecology, bleeding disorders, uterine fibroids, contraception, menopause and vasomotor symptoms, hereditary cancer screening and prenatal counseling. Dr. Lukes advises Health Decisions and our clients on development and implementation of research protocols as well as communications and presentations to the FDA.
An experienced principal investigator in industry-sponsored, NIH and CDC clinical trials, Dr. Lukes has conducted or overseen more than 90 clinical trials of investigational women's health products, including both drugs and devices. Recent experience includes studies of sedation during hysteroscopic tissue removal, treatment of anemia associated with uterine leiomyomas, treatment of vulvovaginal atrophy, transcervical ablation of uterine fibroids, combination drug therapy for management of menstrual bleeding associated with uterine fibroids in premenopausal women, a vapor treatment for excessive uterine bleeding, analgesia for endometriosis-associated pain, pain management during endometrial biopsy, and migraine.
Dr. Lukes' articles have appeared in journals including Obstetrics and Gynecology, the American Journal of Obstetrics and Gynecology, Fertility and Sterility, the Journal of Minimally Invasive Gynecology, Women's Health, Women's Healthcare, Contemporary OB/GYN, the International Journal of Women's Health, Cancer, the British Journal of Hematology, the Journal of Medicine, Current Medical Research & Opinion and Drug Safety. She has served on advisory committees for FDA meetings on topics including a clinician's perspective on thromboembolism, heavy menstrual bleeding and alkaline hematin assessment, and clinical trial design for treatment of vaginal laxity and female sexual dysfunction.
Dr. Lukes founded the Carolina Women's Research and Wellness Center (CWRWC), a leading private gynecologic practice and clinical research center. She also co-founded and served as the Director of Gynecology for the Women's Hemostasis and Thrombosis Clinic at the Duke University Medical Center and founded and chaired the OB/GYN Alliance, an online network of 8,000 OB/GYN physicians in the United States.
Dr. Lukes received a bachelor's degree and a combined medical degree and master's degree in statistics from Duke University. She completed her residency at the University of North Carolina School of Medicine.
Jannine Versi
Elektra Health
Barbara Dehn
Women's Health Practitioner
El Camino Women's Medical Group
Barb Dehn is a practicing Women's Health Nurse Practitioner in Silicon Valley and a television health expert, who's known as Nurse Barb on NBC's California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners. She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.
Tenesha Duncan
Principal, Maternal Health
Tara Health Foundation
Elizabeth Garner
ObsEva
Allison Conti
Watkins-Conti Products
Allison Watkins-Conti is an award winning mentor and serial entrepreneur with a background in marketing & advertising, construction trades and real estate. In 2015, Allison conceived a solution for an issue that affects an estimated 1 in 3 women, worldwide. She designed, patented, engineered and manufactured a solution that is entering the FDA approval process.
Allison Watkins-Conti is an award winning mentor and serial entrepreneur with a background in marketing & advertising, construction trades and real estate. In 2015, Allison conceived a solution for an issue that affects an estimated 1 in 3 women, worldwide. She designed, patented, engineered and manufactured a solution that is entering the FDA approval process. Allison has global intellectual property protection for multiple products, has developed a quality management system, a contract manufacturing facility, conducted studies validating safety and efficacy, and employs some of the top industry leaders in the U.S. Today, Allison develops products to address taboo issues facing women across the globe.
Chandra P. Leo
HBM Partners
Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.
In the women's health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.
Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.
Bill Gruber
Solace Therapeutics
Bill Gruber joined Solace Therapeutics in August 2011 as President and CEO. Prior to this role, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek's V.P. of Sales and Marketing, he built sales from $612K to over $10M. During his last two years, he was the V.P.
Bill Gruber joined Solace Therapeutics in August 2011 as President and CEO. Prior to this role, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek's V.P. of Sales and Marketing, he built sales from $612K to over $10M. During his last two years, he was the V.P. of New Business Development and Marketing. In this role, he was instrumental in creating Soteira, a Cortek subsidiary, focused on devices for treating vertebral compression fractures. Prior to Cortek, Bill spent 10 years at Boston Scientific Corporation. Before leaving Boston Scientific Corporation, he held the position of Director of the $172M Global Atherosclerotic Therapy business. Prior to entering the medical device sector, Bill spent five years in sales and marketing roles at Procter and Gamble.
Amy Welsh
Vice President Marketing
Stasia Obremskey
Rhia Ventures
Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar.
Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor's degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.
Dr Itamar Netzer, OBGYN
Fellow, Healthcare Administration
Ministry of Health, Israel
I am a certified obstetrician and gynecologist, and former Fleet Surgeon of the Israeli Navy (Commander O4, retired). Currently studying Drug and Medical Device Regulation at the Israeli MOH.
I am an analytical, creative and nurturing leader, excelling in creating and maintaining network- or matrix-structure organizations.
My career has the unique characteristics of professional military physicians in Israel, including both high-stakes and decision-making roles in the military, and a full medical professional career in a hospital.
Publication: I am the author or co-author of 15 medical articles and 2 book chapters on the topics of telemedicine, gynecology, or military medicine and presented my academic work extensively in international conferences.
Honors: I was the recipient of two 1st prize awards given by the IDF Chief of the Technology and Logistics Directorate, for Medical Innovation.
My current goals and interests are:
Attaining a leadership position in the medical technology industry, where I may contribute to the future transformation of medical care in terms of personalized, equitable and empathic care driven by advanced tech and caregiver-training.
Jeffrey Erb
McCann Health Engagement
Jeffrey D. Erb is the President of McCann Health: Engagement, the healthcare customer engagement agency within McCann Health and part of the IPG Network. McCann Health Engagement is a leading organization across the globe, developing solutions to most effectively engage with healthcare clients through media and the use of proprietary data applications.
Prior to joining McCann Health, Mr. Erb served as the President of HealixGlobal, the healthcare specialty media agency within IPG Mediabrands, with a market presence and offices in over 100 countries. In his role, he led the organization for several consecutive years of over 50% YOY growth, more than tripled the size of the agency, and lead transformational change in the pharmaceutical media industry on a global level. For over 16 years, Jeff has been a leader in Life Sciences and Healthcare marketing and media. After launching a Pharmaceutical marketing company in 1999 which he sold to a healthcare company, he went on to help large media and marketing agencies launch or reignite their own healthcare divisions.
His experience in defining new strategies for clients in both HCP and Consumer Life Sciences marketing spans from media and analytics, to digital solutions and global pricing strategies. His work has spanned across a wide range in products and therapeutic categories.
His leadership has garnered him a Ben Franklin Award for Most Innovative New Company and he has been featured in numerous television and print news stories, including The Wall Street Journal, Philadelphia Enterpriser Magazine, TSM News, among others, and was named one of the top 100 people to watch by Philadelphia Style Magazine. Most recently he was named a 2019 Top 10 Innovation Catalyst by MM&M Magazine, one of the 2018 Pharma Elite by PM360 Magazine, a Health Influencer 50 by MM&M and received the Innovator of the Year Award from DTC Perspectives. He has also led Healix to win the 3rd Annual Humanitarian Award from Healthcare Marketer's Exchange and to receive the 2018 Most Innovative Company Award from PM 360.
Mr. Erb has frequently spoken nationally as an expert in the fields of media, business development, and technology at events such as Internet World and the Wharton Technology and Media Conference among others. He is a member or has served on the board of numerous business and philanthropic organizations on both a local and National level, including the Medical Marketing Association, and has served as a Director of the Divine Providence Auxiliary Association for handicapped children.
On a personal note, Jeff is an avid investor and producer of feature films, a musician, and he enjoys sailing, skiing and spending time with his family.
Nathan Guerette
Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital
Dr. Nathan Guerette serves as Director and CEO of The Female Pelvic Medicine Institute of Virginia. He is a board certified Urogynecologist specializing in minimally invasive surgical options for pelvic reconstruction and cosmetic surgery including advanced vaginal and robotic surgery as well as non-surgical options. He also holds an appointment as Associate Clinical Professor at the Medical College of Virginia, Virginia Commonwealth University in the division of Urogynecology and serves as Director of Robotic Surgery at Johnston Willis Medical Center.
Prior to moving to Virginia, Dr. Guerette served as Director of Urogynecology at Pennsylvania Hospital, University of Pennsylvania in Philadelphia. Dr. Guerette is board certified in Female Pelvic Medicine and Reconstructive Surgery, Obstetrics and Gynecology as well as Family Medicine. He completed his Fellowship in Female Pelvic Medicine and Reconstructive Pelvic Surgery at the Cleveland Clinic Foundation in 2005 and is the first fellowship trained, board certified Urogynecologist in Central Virginia.
Women's Rights Advocate, Board of Directors
Friends of UNFPA
Minh Ngo is a social justice and women's rights activist, philanthropic leader and social entrepreneur based in Silicon Valley. She has worked with nonprofit organizations, government agencies, and private sector partners to solve intractable problems facing communities. She currently serves as the Executive Director of My New Red Shoes, Board Member and Immediate Past Board Chair of Friends of UNFPA (United Nations Population Fund) and as an Advisor to Community Equity Collaborative, based in Menlo Park. Ms.
Minh Ngo is a social justice and women's rights activist, philanthropic leader and social entrepreneur based in Silicon Valley. She has worked with nonprofit organizations, government agencies, and private sector partners to solve intractable problems facing communities. She currently serves as the Executive Director of My New Red Shoes, Board Member and Immediate Past Board Chair of Friends of UNFPA (United Nations Population Fund) and as an Advisor to Community Equity Collaborative, based in Menlo Park. Ms. Ngo is a graduate of the University of California at Berkeley and Santa Clara University's School of Law.
Jenny Yip
Adjuvant Capital
Dr. Brian A. Bernick
Co-Founder & Chief Scientific Officer
TherapeuticsMD
Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics. Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania. Thereafter, Dr.
Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics. Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania. Thereafter, Dr. Bernick spent over 20 years in private practice in Boca Raton, Florida. During that time, he served as the Chairman of the Department of Obstetrics and Gynecology at Boca Raton Regional Hospital and as an associate professor at Florida Atlantic University College of Medicine. In 2008, Dr. Bernick co-founded TherapeuticsMD, a woman's healthcare company where he has remained part of the executive management and oversees product development and outreach with healthcare providers. TherapeuticsMD is a NASDAQ traded pharmaceutical company with prescription drug products ranging from prenatal care, contraception and menopause. In 2018, TherapeuticsMD obtained 3 new drug approvals. Dr. Bernick is the recipient of several national and regional awards, including recognition by his peers as one of the top doctor's in his specialty. Dr. Bernick has over 100 peer-reviewed publications and presentations of original research at medical conferences. Dr. Bernick holds over 40 US and foreign patents focusing on drug therapies and analysis. Dr. Bernick resides in Boca Raton, Florida with his wife and two kids.
Sherrie Palm
Association for Pelvic Organ Prolapse Support
ENGENDERING THE NEXT SIGNIFICANT SHIFT IN WOMEN'S HEALTH DIRECTIVES
Sherrie Palm carves the trail to de-stigmatize pelvic organ prolapse (POP), a common but rarely acknowledged women's health condition impacting an estimated 50% of women, as she educates and inspires regarding the evolution of women's vaginal and intimate health awareness.
Sherrie Palm is the Founder/CEO of APOPS, Association for Pelvic Organ Prolapse Support, author of 3 editions of the award-winning book Pelvic Organ Prolapse: The Silent Epidemic, an internationally recognized speaker, pelvic organ prolapse advocate, vaginal and intimate health activist, POP key opinion leader, and prolific writer regarding POP physical, emotional, social, sexual, fitness, and employment quality of life impact.
Sherrie has presented speeches nationally and internationally to physician, research, academic, corporate, policy and patient audiences since 2011. Her points of focus are raising awareness of the next significant evolution in women's health awareness, screening, practice, and policy, advancing global women's vaginal and intimate health understanding, developing POP patient guidance and support structures, and bridge building within patient advocacy, white coat, and white collar sectors toward the advancement of women's pelvic health and POP best practices.
Recognizing a need to shift the global view of the remaining stigmatized aspects of women's health, Sherrie Palm takes steps to pioneer change. Cognizant of the diverse and sensitive needs of her audience, Sherrie delicately places all the cards on the table to disclose aspects of vaginal health and intimate wellness rarely effectively discussed. Sherrie's capacity to respectfully and compassionately answer all questions posed during speaking engagements endears her to the audience.
Sherrie's engagement in POP projects and protocol enables patient voice to be an integral part of women's health and wellness evolution. Sherrie presented to the FDA Obstetrics and Gynecology Advisory Committee Panel transvaginal mesh complication meetings in 2011 and 2019, sat on the Pelvic Floor Disorders Stakeholder Advisory Committee from 2011-2013, and currently sits on the FDA Medical Device Epidemiology Network (MDEpiNET) committee. Additional information about APOPS, pelvic organ prolapse, or Ms. Palm's book or speaking presentations is available on the APOPS website.
http://www.pelvicorganprolapsesupport.org/sherrie-palm/
Josie Elias
Program Manager – Digital Health Innovation Group
Mika Nishimura
Operational Partner
Mika Nishimura is a seasoned senior executive with over 20 years of leadership experience in medical device industry.
During her tenure as the Director of Global Marketing at Guidant Vascular Intervention and Vice President, International Sales Operations and Marketing at ev3, Inc., Ms. Nishimura started and built franchises contributing significant, consistent revenue and profit growth with operations in over 30 markets.
In 1999, Ms. Nishimura founded The BLG Group, a leading consulting practice advising both investors and device companies. Her clients have sought her group's advice on critical strategic initiatives ranging from identifying high-priority acquisition targets, developing a product/technology road map based on rigorous analyses and strategic thinking, or creating and executing a geographical expansion plan. She is a frequent speaker at medical device and life science conferences.
In April 2011, Ms. Nishimura became Vice President, Commercial Development for Auxogyn, Inc., an early-stage life science company focused on improving success rates of in-vitro fertilization procedures.
Ms. Nishimura holds an MBA from the Harvard Business School and a BA in Economics with distinction, summa cum laude from Yale University.
Armida Valles-Klute
Executive Director of Managed Care and Financial Clearance
Rachel Braun Scherl
Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
Kristina Cahojova
Dr Taraneh Shirazian
Gynaecologic Surgeon, Assistant Professor Center; President and Founder, Saving Mothers
NYU Langone Medical
As a board certified gynecologist at NYU Langone, I specialize in minimally invasive gynecologic surgery and the management of many common health issues affecting women. These include uterine fibroids, ovarian cysts, abnormal uterine bleeding, abnormal pap smears, uterine prolapse, and menopause. I also treat women who have received an abnormal Pap test result.
In the office, I perform procedures such as loop electrosurgical excision to diagnose abnormal or cancerous conditions, hysteroscopy to examine the uterus, and colposcopy to examine the cervix, vagina, and vulva.
I perform all types of surgeries for benign gynecological conditions, such as endometriosis, uterine fibroids, and ovarian cysts. These procedures include laparoscopic, minimally invasive surgeries, such as myomectomy, hysterectomy, and ovarian cystectomy.
In my practice, I emphasize patient education and empowerment. I take the time to ensure that every woman I see understands the details of her condition and has the knowledge to make the best decisions about treatment.
As the director of Global Women's Health in NYU's College of Global Public Health, I actively research and raise awareness about global health and women's health issues. I also serve as the president and medical director of Saving Mothers, a nonprofit organization I founded that focuses on women's health, education, and empowerment in low resource regions.
My research focuses on interventions that can help to reduce the number of women who die during pregnancy or childbirth around the world. In addition, I have coauthored a book, Around the Globe for Women's Health: A Practical Guide for the Health Care Provider, and am frequently called on for my expertise in women's health by national media outlets, such as CBS News, The Today Show, and Good Morning America. I have been quoted in the Wall Street Journal, Women's Day, Newsweek, and the New York Daily News.
Through the treatment I offer to patients, as well as my research and engagement with media outlets, I always strive to be an advocate for women, both locally and globally, and to champion women's health education and self-empowerment.
Aarathi Singh
Medgyn
Aarathi Singh is a senior executive in the medical device industry with 15+ years of strategy and operating experience. She has a strong background in marketing, sales force optimization, and the commercialization of innovative technologies. Aarathi is Chief Operating Officer of MedGyn, a global manufacturer and distributor for women's health products.
Aarathi Singh is a senior executive in the medical device industry with 15+ years of strategy and operating experience. She has a strong background in marketing, sales force optimization, and the commercialization of innovative technologies. Aarathi is Chief Operating Officer of MedGyn, a global manufacturer and distributor for women's health products. Through Aarathi's leadership the company has expanded into international markets and new product lines to address the unmet needs in women's health throughout the world, including partnerships with governments, NGOs, and leading healthcare organizations. Prior to joining MedGyn, Aarathi held positions of increasing responsibility at Deloitte Consulting and at Johnson & Johnson. Aarathi has a BS in Finance from Boston University and a MBA from Northwestern University Kellogg School of Management.
https://profiles.forbes.com/members/business/profile/Aarathi-Singh-Chief-Operating-Officer-MedGyn-Products-Inc/d3266977-8ed8-4278-abb8-e1780cea8884
Dr Jin Lee, Ph.D
Director Digital Health Product / Commercial Strategy
Dr. Jin Lee is the Director of Digital Health Product/ Commercial Strategy at Astellas pharma. She most recently was the CEO and founder of BabyNoggin, a maternal/child app platform screening for postpartum depression and child's development issues and help those connect to additional care as needed. She was formerly at the innovation centers and venture arms of Humana, 4th largest health insurance company, and Providence St. Joseph Health, 3rd largest nonprofit hospital system, focused on series A & B digital health investments. Based in San Francisco, Dr.
Dr. Jin Lee is the Director of Digital Health Product/ Commercial Strategy at Astellas pharma. She most recently was the CEO and founder of BabyNoggin, a maternal/child app platform screening for postpartum depression and child's development issues and help those connect to additional care as needed. She was formerly at the innovation centers and venture arms of Humana, 4th largest health insurance company, and Providence St. Joseph Health, 3rd largest nonprofit hospital system, focused on series A & B digital health investments. Based in San Francisco, Dr. Lee advises multiple digital health startups and accelerator programs. She received her Ph.D in neuropsychology from the University of Oxford and BA in biology and neuroscience from the University of Pennsylvania.
Jarrad Aguirre, MD, MBA
Lisa Larkin
Ms Medicine
Sofia Noori MD, MPH
Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department
Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good. She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr.
Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good. She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr. Noori is a 2019 scholar at Flare Capital Partners in Boston, MA.
Aside from her endeavors in digital health, Dr. Noori deeply cares about the wellbeing of women. She is the co-founder of the Women's Mental Health Conference at Yale, the first trainee-led women's mental health conference in the world. Dr. Noori also co-founded the Yale Women's Housestaff Organization, which advocates for improved working conditions for the over 700 women residents and fellows at Yale.
Dr. Noori is an MD graduate of the PRIME program at UCSF School of Medicine, a dual-degree program that trains emerging physician-leaders to transform care for underserved populations. She received her MPH in health policy and management at UC Berkeley. She is passionate about women's mental health and the use of technology to improve health equity.
Holly Rockweiler
Madorra
Meghan Rivera
Vice President and Head of Sales & Marketing Women's Health
AMAG Pharma
Anula Jayasuriya
EXXclaim Capital
Debra Bass
U.S. President and Chief Marketing Officer
Nuvo Group
Keren Leshem, MBA
OCON Healthcare
Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.
Hadine Joffe
Mary Horrigan Conners Center for Women's Health and Gender Biology, Brigham and Women's Hospital
Teo Tijerina
Hera Diagnostics
Anne Morrissey
Former President & CEO
Alydia Health
Eric Dy
Bloomlife
Marta Hill Gray
Gray Matter Group
Elizabeth Bailey
Director of Investments
Tanya Abreu
Healthcare Futurist & Health Network Strategist
Lawler Kang
League of Allies
I am presently running League of Allies, a professional services firm focused on helping our clients benefit from "inclusive synergy", the material improvement of both operating and investment performance generated by minimizing dominant culture groupthink. The League was profoundly influenced by researching my second book, The E Ticket.
Chief People Officer at Rue La La, a leading force in the evolution of e-commerce.
Running People Strategy and Talent Acquisition for a health-care focused innovation software consultancy with offices in Cambridge, Washington DC, Trinidad, and Jamaica.
Authoring a book, Passion at Work (Pearson Prentice Hall) that led to a speaking/workshop business that has serviced organizations from startups to Fortune 50 concerns.
Running four turnarounds, from software/services to bio-tech.
Serving as an Engagement Manager in the venture funded business unit at Scient, an eBusiness consulting firm, and then Managing Director of the Northeast, growing the presence to 85 amazing Colleagues.
Staffing revolutions in an executive search capacity.
Specialties: Executive Management, Belonging/Engagement/Retention, Leadership, Start Ups, Motivational Speaking, Consulting, Strategy, Human Assets, Talent Acquisition, Turn Around Management, High-Growth Environments, Writing
Ariana Tiwari
Associate Marketing Manager
Renew Life/Clorox
At Renew Life, Ariana Tiwari is responsible for developing and launching science-backed probiotic products, crafting innovative marketing campaigns highlighting women's digestive issues, and building business cases for innovation focused on the female microbiome. Before joining Renew Life's brand marketing team, she worked on infrastructure projects at the International Finance Corporation, a part of the World Bank Group, and on healthcare deals in the investment banking division of Credit Suisse.
At Renew Life, Ariana Tiwari is responsible for developing and launching science-backed probiotic products, crafting innovative marketing campaigns highlighting women's digestive issues, and building business cases for innovation focused on the female microbiome. Before joining Renew Life's brand marketing team, she worked on infrastructure projects at the International Finance Corporation, a part of the World Bank Group, and on healthcare deals in the investment banking division of Credit Suisse. In her spare time, she teaches yoga in San Francisco; launched the DC chapter of Off Their Plate, a non-profit that re-employs restaurant workers in order to feed healthcare professionals on the frontlines of fighting COVID-19; and aspires to taste every wine in Napa Valley. Ariana holds a B.A. from Princeton University and an M.B.A. from Harvard Business School.
Zac Lewis, PhD
R&D Senior Scientist
Zac is an R&D Senior Scientist for the Renew Life brand.
He holds a Ph.D. in Microbiology from the University of California, Davis; and was awarded a prestigious Alfred P. Sloan Foundation postdoctoral fellowship
He has extensive expertise in Bifidobacterial genetics and physiology, as well as experience measuring bacterial abundances using state-of-the-art DNA sequencing techniques. He currently leads the development of probiotic and prebiotic products, and is the point person for Renew Life's clinical trials program. He also provides subject matter expertise on the human microbiome.
Rob Royea
Cyrcadia Asia
Colette Courtion
JoyLux
Liz Klinger
Trish Costello
Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty.
Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.
Elizabeth Jeffords
Chief Commercial & Strategy Officer
Linda Greub
Avestria
Leah Sparks
Wildflower Health
Leah Sparks, CEO & Founder of Wildflower Health, has more than 15 years experience building innovative healthcare businesses in both venture-backed companies and Fortune 50 corporations. Leah founded Wildflower Health in 2012 while starting a family of her own and seeing firsthand the gaps in healthcare for consumers.
Prior to starting Wildflower Health, Leah led business development for a personalized medicine startup that was acquired by Medco a few years after she joined the company. She began her career in healthcare at McKesson Corporation in corporate development, where she focused on strategy and M&A. During her tenure at McKesson, she held a variety of leadership roles including spearheading the company's entry into the oncology market.
Dr Benjamin Brucker, MD
Urologist, MD
One of my grandfathers was a general surgeon and the other was an obstetrician—I chose a specialty that is the perfect blend of their fields. I specialize in urology, urogynecology, and surgery, and I help to manage bladder problems, incontinence, urinary tract infections, pelvic organ prolapse, and other conditions.
I use a combination of traditional approaches and advanced, minimally invasive techniques to improve safety, speed of recovery, and outcomes for my patients. I maintain wonderful relationships with my patients and find it incredibly rewarding to help them by managing their conditions and performing surgeries.
It is vital for physicians to completely understand how a condition affects a patient. To do so, we must be familiar with the person's overall health, sense of wellbeing, and quality of life, as well as the impact of the condition on the person's relationships and families.
Having this information helps me to create individualized treatment plans. Treatments cannot be "one size fits all," because every patient experience is unique. Our team, regarded as one of the best in the world, pays close attention to each person's needs and diagnosis.
In addition to treating patients, I conduct research on incontinence, the effects of multiple sclerosis and neurologic disorders on the bladder, and treatment of people with overactive bladder and benign prostatic hyperplasia, or an enlarged prostate. I'm very fortunate to have received a grant from the Allergan Foundation to continue my research on incontinence. This funding also enables me to train future leaders in the field.
I am proud to have been selected by Super Doctors for a "Rising Star" distinction in the New York Metro area and by The Leading Physicians of the World for a "Top Urologist" award.
Amy Beckley
MFB Fertility
Amy has a PhD in Pharmacology and expertise in hormone signaling. She also had a three year battle with infertility. After self-diagnosing her own causes of infertility and saving herself from more rounds of in vitro fertilization (IVF), she invented Proov to help women have access to their hormonal health to conceive faster
Nicole Leeds
Go-To-Business Strategy
Clue (digital period tracker)
Nicole is the Head of Monetization and New Business at Clue, where she focuses on new revenue models, B2B partnerships, and company strategy. With over 12 million users worldwide, Clue is one of the most popular apps in the health category and has been rated the top free period tracker app by the journal Obstetrics & Gynecology, a publication of the American College of Obstetricians and Gynecologists (ACOG).
Nicole has previously worked in digital health, medical devices, and global development in Germany, India, Rwanda and the United States. Her background includes the international medical devices business on Medtronic's corporate strategy team, global health equity work with the Global Health Corps and the Clinton Health Access Initiative, and strategy consulting with the Bridgespan Group.
Dr. Raoul Scherwitzl
Jeff Trost
Laerdal Million Lives Fund
Sateria Venable
The Fibroid Foundation
Sateria Venable is the Founder & CEO of The Fibroid Foundation (www.fibroidfoundation.org), a global, patient-founded advocacy organization.
The Fibroid Foundation develops programming to support its community of over 25,000 women. Sateria began her advocacy efforts in 2007. Since that time, the organization has developed a substantial network within the medical community.
Venable, who holds a Bachelor of Architecture from Carnegie Mellon University, has co-authored several scientific papers on fibroid research. She is the inventor of an undergarment inspired by her journey, that she hopes will transform intimate apparel for all women. A sought-after speaker, she has been featured in print and radio media, and has presented at gynecologic conferences worldwide.
Surbhi Sarna
nVision Medical, Boston Scientific Company
In 2018, at the age of 32, Surbhi Sarna sold her company to Boston Scientific for $275M. Her entrepreneurial journey started nearly two decades before that moment. Surbhi was only thirteen years old, writing an essay for her English class, when all of a sudden she felt such a sharp pain her side that she blacked out. She didn't know it then, but that would be one of the most defining moments of her life. After six months, she finally got her diagnosis - she was suffering from complex ovarian cysts, but there was no way to know whether or not those cysts were cancerous.
In 2018, at the age of 32, Surbhi Sarna sold her company to Boston Scientific for $275M. Her entrepreneurial journey started nearly two decades before that moment. Surbhi was only thirteen years old, writing an essay for her English class, when all of a sudden she felt such a sharp pain her side that she blacked out. She didn't know it then, but that would be one of the most defining moments of her life. After six months, she finally got her diagnosis - she was suffering from complex ovarian cysts, but there was no way to know whether or not those cysts were cancerous. From the unnecessarily long diagnostic time to the lack of therapeutic options, she knew she wanted to work on innovation in the healthcare space. Her talk will be about her entrepreneurial journey, what it takes to raise money and hire a season team, break down barriers around you and finally get to an exit.
Annie Theriault
Cross Border Impact Ventures
Nadia Ramey
Senior Director, Health IT and Clinical Informatics
Nadia Ramey has over 15 years of experience working in heath IT, clinical research, and digital health. She is currently the Senior Director of Health IT and Clinical Informatics at the American College of Obstetricians and Gynecologists (ACOG). In this role, she is responsible for developing the strategic plan, mission, and objectives in her department to improve health outcomes for women through the use of digital platforms. Dr.
Nadia Ramey has over 15 years of experience working in heath IT, clinical research, and digital health. She is currently the Senior Director of Health IT and Clinical Informatics at the American College of Obstetricians and Gynecologists (ACOG). In this role, she is responsible for developing the strategic plan, mission, and objectives in her department to improve health outcomes for women through the use of digital platforms. Dr. Ramey is working to build on the health IT projects within ACOG and establish new partnerships and opportunities to develop a world class health IT and clinical informatics initiative. Some of these projects include clinical content curation, digital health, clinical decisions support, health IT standards, and data aggregation. Most recently, Dr. Ramey's interests in women's digital health has focused on perinatal anxiety and digitizing clinical guidelines. She is a strong supporter of technology to improve the delivery of care and clinical outcomes for women.
Tracy MacNeal
Rob Binney
Donna Parr
Cross-Border Impact Ventures
Marga Ortigas-Wedekind
Chief Commercial Strategy Officer
Fogarty Institute for Innovation
Kristina Saffran
Equip Behavioral Health
The case for her
Jennifer "Jay" Palumbo
Freelance Writer and Women's Health Advocate
Mary Kerr
KaNDy Therapeutics
Berthold Hinzen
Head Business Development, Licensing & Alliance Management New Spaces, Radiology, Women's Health
Bayer Pharmaceuticals
Erica Kantor
Medical Sector Manager
Sagentia
Dr. Eileen Buttimer
Managing Partner – Consumer Advisory
Oakland Advisory
Ravit Warsha Dor
Kamet Ventures
Caroline Noublanche
Apricity
Claudia Reuter
General Manager, Americas East
Claudia Reuter is an experienced entrepreneur, executive and board director, and a published author. Recognized by the Boston Business Journal as a 2016 Women to Watch in Science and Technology, and as a Changemaker by HUBWeek, she currently serves as GM Americas East for Techstars. She is also a member of the board of directors of Lessonly, and a member of the editorial advisory board for Innovation Leader.
Claudia Reuter is an experienced entrepreneur, executive and board director, and a published author. Recognized by the Boston Business Journal as a 2016 Women to Watch in Science and Technology, and as a Changemaker by HUBWeek, she currently serves as GM Americas East for Techstars. She is also a member of the board of directors of Lessonly, and a member of the editorial advisory board for Innovation Leader. Prior to joining Techstars, she served as the SVP of Digital Services & Labs for Houghton Mifflin Harcourt, and was the co-founder and CEO of SchoolChapters. A graduate of the University of Vermont, she is also a lifelong learner and has completed additional coursework at institutions including RISD, MIT Sloan, and Trinity College. She is also a graduate of Lead Boston, an experiential program focused on inclusive leadership. Passionate about sharing more stories about what's possible for women she is also the creator and host of the podcast, "The 43 Percent." which was featured on Apple's New & Noteworthy list, and selected as an editors choice by Stitcher and Himalaya App. Her book, "Yes, You Can Do This! How Women Start Up, Scale Up, and Build the Life They Want.' (Wiley 2020) is available now.
Lucy Setian
Digital & AI Stakeholder Engagement Lead
Novartis Foundation
Dr. Karolynn Echols
Director, Section FPMRS Associate Professor, Department of Obstetrics and Gynecology
Sabrina Badir
Pregnolia
Neil Ray, MD
Raydiant Oximetry
Dee Harmann
Center for Genital Health and Education
Dr Lyndsey Harper MD, FACOG IF
Dr. Pepper Schwartz
Sexual Health Expert
Past President of the Society for Scientific Study of Sexualities
Reena Pande
AbleTO
Patricia Simon
Assistant Professor, Adjunct Director, Innovation to Impact Division of Prevention and Community Research
Yale University School of Medicine
Julie Bernstein
Reenita Das
Christina Jenkins
Venture Investor and Strategic Advisor
Christina Jenkins MD is a venture investor and strategic advisor with expertise spanning clinical medicine, venture capital, health systems, and managed care organizations. Her knowledge of healthcare providers, payers, and consumers enables successful innovation, growth, and improved outcomes.
As a Venture Partner for Portfolia's FemTech and Active Aging and Longevity Funds, Dr. Jenkins invests in early-stage companies targeting women's health, or that seek to leverage women's role as primary health decisionmaker and caregiver.
She also serves as Executive Advisor for Lucania Partners, working alongside healthcare leaders to implement growth and redesign strategies. Previously, Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals (H+H) built to establish population health and value-based payment capabilities for 1M lives.
Dr. Jenkins is a Board Director for Independence Health Group (parent of Independence Blue Cross), a Board Observer for Madorra, and an advisor to value-generating healthcare companies including Visiting Nurse Service of New York, Elektra, Incredible Health, Babyscripts, and Wellth.
Kathy Kaluhiokalani
Advantia Health
Kathy Kaluhiokalani is a veteran healthcare industry leader and the Chief Operating Officer of Advantia Health. Kaluhiokalani oversees payer relations, integration, and operations for the company's practices and technology.
Tracey McNeill
VP Clinical Governance & Quality
Tracey McNeill is currently VP Clinical Governance & Quality at Babylon Health, leading the team responsible for ensuring clinical standards are consistently implemented and audited across the globe. Prior to this, Tracey was Chief Mobilisation Officer where she was responsible for facilitating the set-up of Babylon clinical services into new and exciting markets, most recently this included the Babylon Telus partnership in Canada.
Tracey was previously CEO of Babyl Rwanda, for 3 years she lived and worked in Rwanda establishing Africa's first fully integrated digital health service into the Rwandan health system. By using digital health technology as an enabler with AI in government health posts and facilities, she has been helping transform the delivery of health care to the entire population by offering accessible and affordable health care to all. The results have been exceptional with Babyl now having completed 1 million digital health consultations since launch.
Tracey is an experienced international healthcare operations executive, having worked extensively in a diverse range of sensitive healthcare settings globally. She has worked in the developing world for both private sector and NGO's that transform the lives of people. Tracey has lead many public/private sector partnerships to re-design health delivery systems. She was formerly SVP and Commercial Director of Marie Stope's International with responsibility for commercialising many of its international programs through delivering sustainable solutions.
Please complete the form to access the 2020 Women's Health Innovation Summit (WHIS) Agenda and register your interest to WHIS 2021.
Take a look at 2019 highlights:
REGISTER YOUR INTEREST FOR WOMEN'S HEALTH INNOVATION 2021
The Virtual Experience
Top 10 benefits
- Tailor Your Agenda
- More Audience Participation
- Improved Audience Visibility
- On-Demand Content
- High Quality Speakers
- More Networking Opportunities
- Save Time & Money
- Increased Content
- More insights
- Business Development Opportunities - Talk to our team to find out out more [email protected].
Platform Preview
APPLY NOW: INNOVATION SHOWCASE
SAMPLE ATTENDEES 2020
CASE STUDY: WOMEN'S HEALTH CLINICAL RESEARCH
Post-Show Report 2019 - Women's Health Innovation Summit
Sample Attendee List
FemTech Market Map
5 Reasons to Invest in Women's Health
Natural Cycles Interview
Evofem Interview
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or 'Start-Up' rates
Book a Team of 3+ - Save an Additional 10% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
We accept the following cards through Stripe:
TICKET PRICES INCREASE IN
Sunday, September 6, 2020 to Tuesday, September 22, 2020
4 DAY PASS: START-UPS & INVESTORS (less than $10 million)
+ Register Now
5 Day Access
FemTech & Digital Health Companies, incl. Venture Capital, Angel Investors
Networking & 1-2-1 meetings
Want to partner? Contact [email protected]
4 DAY PASS: INDUSTRY
Pharma, Biotech, Medical Devices, Multinational & Corporate (over $10 million)
4 DAY PASS: SERVICE PROVIDERS
Consultants & Industry Vendors, Investment Banks, Private Equity
Tuesday, September 8, 2020 to Tuesday, September 22, 2020
ONE DAY ONLY PASS
EVENT & PLATFORM ACCESS FOR ONE DAY ONLY
Access to 1-2-1 Networking Platform (to book meetings for one day)
Innovators: Virtual Display Package
Includes 2 Passes (Start-ups Only)
X2 Event Passes
Early Access to 1-2-1 Networking Platform (to book meetings)
Video on the event Innovation Hub highlighting your innovation/solution
Preparing registration...
Website: https://www.healthdec.com/
Health Decisions is a full-service CRO specializing in the clinical development of women's health and diagnostics assets. Health Decisions has supported more than 200 clinical trials in women's health indications including contraception, menstrual disorders, menopausal symptoms and risk of preterm birth.
Website: https://www.goodwinlaw.com/
Please visit our website for more information.
Event Partner
Watkins-Conti Products Inc
Website: http://www.watkinscontiproducts.com/
Watkins Conti Products, Inc. is a Female founded and owned, Platform Women's Healthcare company and product design firm that is focused on the creation of innovative and affordable consumer medical devices.
The company's flagship product is a non-invasive solution for stress incontinence in women. The problem impacts and estimated ONE in THREE women globally. The disruptive, patented product offers multiple recurring revenue streams. Watkins-Conti has additional products in the pipeline to improve the consumer experience, specifically for health related issues that women face that are often seen as shameful or taboo.
Frost and Sullivan
Website: https://ww2.frost.com/
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.
FemTech Collective
Website: https://femtechcollective.com/
FemTech Collective is the world's largest network for entrepreneurs, innovators, and professionals interested in amplifying the women's health technology ecosystem. Our mission is to catalyze quality innovation by providing a strategic platform for the FemTech ecosystem in order to create and grow better products and services to accelerate female health.
If you're interested in becoming a media partner, please contact Katie Horne: [email protected]
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical 'meet-and-greet' exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that's why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Virtual Event & 1-2-1 Meeting Platform
The second annual Women's Health Innovation Summit will be taking place digitally. You can access the event from anywhere in the world - including your living room!
Join us on our ultra engaging Virtual Event & 1-2-1 Meeting Platform.
Ask questions, vote in polls and participate in group discussions in real time
Greater access to attendees - see them all and send them a direct message
Participate in round tables, games, interative sessions or just listen to our world leading speakers
Endless possibilities to achieve your business and personal objectives with us online
Got questions? Send us an email at [email protected]
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
Contact us at +44 (0)20 3696 2920 and email [email protected], or let us know what subject area you're interested in below.
© 2021 Kisaco Research.
Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Other events you might be interested in:
Personalized Beauty Summit 2021


Help us improve the CDR – tell us what you know about 'Strathmore Paper Packaging'.
amazing to see what happens when companies invest in good design. office life would be sweeter if more of these types of mundane supplies were packaged like this (art!).
We love design but sometimes we even surprise ourselves at how great it can be. To find out more go to http://www.feltandwire.com.


Through the thousands of images on the net about 2020 chrysler 300c, we selects the very best collections having ideal quality only for you all, and now this images is actually one of photographs collections inside our ideal photographs gallery about 2020 chrysler 300c. I'm hoping you may want it.
That picture (2018 Chrysler Imperial Youtube within 2020 chrysler 300c) earlier mentioned is branded having:posted through admin with May, 23 2018. To see many photographs inside 2020 chrysler 300c photographs gallery you should abide by this specific link.


text:
Home » Sheet Music » Understanding The Low Clarinets, by Saunders & Siennicki | CAMco
Understanding The Low Clarinets
by Richard T. Saunders & Edmund J. Siennicki
Bass Clarinet 1
Richard T. Saunders (1928–2020) was an American clarinettist, and Edmund J. Siennicki (1920–2014) was an American composer, teacher, and conductor. Their book Understanding the Low Clarinets, published in 1972, is designed to "...aid the student who has a fundamental knowledge of clarinet playing in transferring from one member of the clarinet choir to another." Through the collection of exercises, études, and solo material, one can "...overcome tonal and technical difficulties and develop the correct style and approach to peculiar to these instruments."
There are six pages of brief, basic information about reed selection/care, posture and hand position, embouchure, articulation, intonation, and transposition.
The 19 daily exercises are spread over seven pages. The first portion consists of slow, sequential passages, 3–4 lines long, to "warm up" the basic range of the instrument, encouraging proper voicing and smooth note connections. The second portion focuses on articulation and basic finger technique. Most exercises are written out in a single key, and instruct to play in all keys and registers.
Daily exercises:
Time signature: 3/4, 4/4
Key signature: no ♯/♭, 1♯, 1♭
Range: low to high = written E3–C♯6
The étude section begins with a one-page "Transposition Étude" for the E-flat contralto clarinet with preceding guide; since the instrument usually reads from bass tuba or bassoon parts in bass cleff, transposing such parts for treble cleff is an advisable skill. This is followed by 11 études, each one page long (a few are slightly longer). They are organized with increasing difficulty through time signature and key signature variety. The rhythms start with mostly quarter- and eighth-notes in the early études, and add complexity and density in numbers 9–11 with dotted rhythms, sixteenth-notes, and triplets.
11 études (plus transposition étude in treble cleff):
Time signature: 2/2, 2/4, 3/4, 4/4, 5/4, 6/4, 7/4, 12/8
Key signature: no ♯/♭, 1♯, 2♯, 7♯, 1♭, 2♭, 3♭
Range: low to high = written E3–D6
The book finishes with 3 short works for clarinet and piano by Edmund J. Siennicki. Each work includes a solo part transposed for 4 different low clarinets: E-flat alto, B-flat bass, E-flat contralto, and B-flat contrabass. The solo and piano parts are attached in a single book binding, so use of the material in rehearsal or performance will require multiple copies. Nocturne (3.5 minutes) features a slow 5/4 meter for much of the piece, and is marked Moderato cantabile. Passacaglia (4 minutes) passes through a handful of lively moods, strung together by an ever-present bass-line motif. Impromptu (2 minutes) is the most technically demanding of the three; it is written entirely in triplets, has frequently shifting time signatures and ambiguous harmonies.
3 works with piano:
Time signature: 2/4, 3/4, 4/4, 5/4, 12/8
Key signature: no ♯/♭, 1♭ (B♭ bass clarinet)
Range: low to high = written D♯–C♯6 (B♭ bass clarinet)
As noted by the writers, this book is not meant for a beginner clarinettist, but instead for someone looking to hone their clarinet skills across the low clarinet family members. The technical demands are very approachable for one early in their development, and the études and solo performance works appearing later in the book will provide a healthy, moderate challenge.
Pages (score): 11
Publisher Code: LA0115

redpajama_set_name: RedPajamaCommonCrawl


It appears that CERN is going beyond the "God Particle" with their "Creator Project". Symmetry resembles Islamic Sufism mystic "Sufi" dance. Reports say the funding for CERN is funneled through Carbon and Global Warming taxes.
Sufi dance is a mystical type of worship and trance like meditation from the more modern form to primitive form. Even Stephen Hawkings warned "The God Particle" could end up killing us.
The Clintons' entire political careers, including Chelsea, have been focused on buzz words like "new social contract," "paradigm shift," and "third universe". The Clinton administration opened the door to international trade agreements and passage of N.A.F.T.A. Act. Few understand the connection with "trade" and beast system. Karl Marx's mentor created philosophy of Master-Slave dialectic.
It seems the Kabbalah Communist theory has succeeded in completing tzimtzum on the Christian nation. Romans 1:28 When you create a vacuum its opposite and equal reaction will flood in.


text:
RBC fined $1-million by Finra on sales of reverse convertibles
Doug Alexander
Outside the Royal Bank of Canada office tower in Toronto's Financial District.Fred Lum/The Globe and Mail
Royal Bank of Canada was fined $1-million and ordered to pay about $434,000 in restitution by a Wall Street regulator over sales of reverse convertible securities.
Royal Bank's capital-markets unit failed to adequately supervise the sale of 364 transactions in 218 accounts that were unsuitable for those customers, the Financial Industry Regulatory Authority said Thursday in a statement. Reverse convertibles are interest-bearing notes in which repayment of principal is tied to the performance of an underlying asset, such as a stock or basket of stocks.
RBC Capital Markets didn't admit or deny the charges, according to the statement.
RBC expands investment banking business in Paris
Canada's banks form consortium to deal with Apple Pay: reports
RBC's McKay favours U.S. among 'core' markets


Hideki Irabu card courtesy of http://japanesebaseballcards.blogspot.com/2011/07/rip-hideki-irabu.html.
This entry was posted on January 23, 2015 at 2:16 pm and is filed under non-de Jesus related.	You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.


text:
QC Traffic Cameras
Download The B100 App
Adele In Las Vegas
B100 On Alexa
Open House Party
Brooke and Jeffrey
Connor Kenney
B100 App
Home Run Ball from Field of Dreams Game Just Recovered in the Cornfield
James Patrick
James Patrick Published: October 12, 2021
Fox Sports, YouTube
On August 12th in Dyersville, the Chicago White Sox played and defeated the New York Yankees 9-8 in dramatic fashion as Tim Anderson delivered a walk-off home run in the bottom of the 9th.
Altogether, eight home runs were mashed into the cornfields on that hot and humid summer evening.
But were all those home run balls recovered?
Nearly two months later, one of the eight home run balls was discovered beyond the left-center field fence by one of the staff members at the Field of Dreams.
On October 7th, The Field of Dreams Movie Site Twitter Account tweeted that one of their employees had possibly recovered one of the home run balls from the historic game.
If indeed it IS one of the home runs balls from the game, who hit it? Remember, it was found in the area just left of center field.
NOT Jose Abreu. In the bottom of the first inning, Abreu hit his 23rd round-tripper just over the left-field fence.
NOT EITHER of Aaron Judge's blasts. In the third inning, #99 homered to right field and in the ninth inning, he also homered to right. So it wasn't either of those balls.
In the third inning, Eloy Jimenez also homered to right field, so it wasn't his ball that was found.
White Sox catcher Seby Zavala launched his two-run homer to right field in the 4th inning.
Yankees veteran Brett Gardner homered to right field in the sixth inning and the game-winner slugged by White Sox shortstop Tim Anderson was also hit to right field.
That leaves only Giancarlo Stanton's mammoth home run in the top of the ninth that gave the Yankees the lead.
Here's every home run that was hit that night:
Former Waterloo Bucks Players Now On Major League Baseball Rosters
LOOK: 50 images of winning moments from sports history
Sometimes images are the best way to honor the figures we've lost. When tragedy swiftly reminds us that sports are far from the most consequential thing in life, we can still look back on an athlete's winning moment that felt larger than life, remaining grateful for their sacrifice on the court and bringing joy to millions.
Read on to explore the full collection of 50 images Stacker compiled showcasing various iconic winning moments in sports history. Covering achievements from a multitude of sports, these images represent stunning personal achievements, team championships, and athletic perseverance.
Filed Under: Field of Dreams, home run ball, nl
2022 B100, Townsquare Media, Inc. All rights reserved.


Shari Hawke is a member in our Singapore office and specialises in advising clients on law aspects of corporate and private equity transactions in the British Virgin Islands and Cayman Islands. Her clients include international and domestic corporates, financial institutions and private equity funds.
Prior to joining us, Shari began her career with Clayton Utz in Australia and subsequently worked as a senior associate at Freshfields Bruckhaus Deringer in Singapore and Hong Kong. She then worked at Allen & Overy in Singapore before moving offshore. Shari regularly advises on structuring, negotiating and documenting investments in a broad range of complex, cross-border transactions in both established and emerging markets. Her expertise includes public and private mergers and acquisitions, takeovers, disposals, management buy-outs, strategic joint ventures and corporate restructurings.


text:
Q: R Shiny Error with ggplot I trying to develop a simple Shiny APP to display a bar chart. In the example I'm following (https://shiny.rstudio.com/gallery/telephones-by-region.html) the plot is Phone by Region. I want simpler: just a count by candidate (my data: dados).
The main problem is with the input command inside the bar plot code. The original
barplot(WorldPhones[,input$region]*1000,
        main=input$region,
        ylab="Number of Telephones",
        xlab="Year")

should be substituted by
ggplot(data=dados, aes(x=dados[input$candidato])) +
  geom_bar(stat="count")

Doing this, I got the error:

Don't know how to automatically pick scale for object of type
  tbl_df/tbl/data.frame. Defaulting to continuous. Warning: Error in :
  Discrete value supplied to continuous scale

Data sample:
Candidato1 Candidato2 Candidato3
      <chr>             <chr>             <chr>

POSITIVO          NEGATIVO          POSITIVO          POSITIVO
NEGATIVO          POSITIVO          NEGATIVO          NEGATIVO
POSITIVO          POSITIVO          NEGATIVO          NEGATIVO
How can I solve this? Appears that ggplot can't accept my string, but outside shiny, works fine.
Tks, Ricardo.

A: It is very hard to understand Your question, actually You should explain it more briefly...
While looking at Your code, i can straight tell You that the problem is this part of code:
aes(x=dados[input$candidato])

You havent defined well if input$candidato should filter out the rows or columns....
I assume You meant columns, then the code should look like that:
 aes(x=dados[, input$candidato])

redpajama_set_name: RedPajamaStackExchange


The flag bearer of the opposition New Patriotic Party (NPP), Nana Akufo-Addo has described the ruling National Democratic Congress' "Better Ghana Agenda" as a "spectacular failure".
The NPP flag bearer said Ghana cannot afford to continue operating "an agrarian, raw material producing and exporting economy. It cannot generate the prosperity and the thousands of jobs that the economy demands".
Nana Akuffo Addo, who was addressing some students of the University of Ghana as part of his Greater Accra tour said "Ghana has to make a deliberate, conscious effort to modernize and industrialize the economy and make it a value adding one".
According to Nana Akufo-Addo, the NPP has tasked itself to pursuing the transformation of the economy which he added, could not be done without a competitive workforce- an educated and dynamic population- "that is the rationale for our educational policy because the rationale requires we guarantee access to all the youth of our nation to education".
According to Akufo-Addo, the only way access to education can be guaranteed is for the state to take the burden of supporting education up to the end SHS. He added that the NPP has done the costing of the Free SHS policy and he was confident that Ghana can afford it.
The NPP flag bearer stated that the very people doubting the feasibility of the Free SHS policy were the same who doubted the feasibility of the National Health Insurance Scheme among others.
He also added that the Free SHS policy will be achievable if the country is able to reduce corruption and waste in the financial management of the country.
He called on the students not to retain the "failed policies" and "failed personalities" in power as the country heads for the December 7 polls.
Rather, Nana Akufo-Addo urged the students to embrace the NPP's social and economic transformational agenda it has spelt out in its manifesto.


It is a sign of things to come, perhaps. Two evangelists in Britain were prevented from handing out tracts of Scripture by a Muslim community police-officer. They were accused of a hate-crime for trying to convert Muslims to Christianity. the two evangelists were Americans. They are pressing the police authority for an apology and threatening to take the issue to court if one isn't forthcoming. See the full story, here.


Most customers do not expect to be hurt by store merchandise when they go shopping. Yet, each year dozens of individuals are injured due to "falling merchandise." The following Louisiana First Circuit Court of Appeal ("the Court") case is a perfect example of what happens when an individual seeks legal action for being injured by a store's falling merchandise.
Darry Hughes and his co-worker sought to purchase a plastic storage bin from Home Depot for their East Baton Rouge office. Inside the store, Hughes was injured when he removed a plastic bin from a shelf using both hands and was unable to stop another bin behind it from falling onto his face. Hughes brought a lawsuit against Home Depot U.S.A. ("Home Depot") for the injuries he sustained from the alleged incident on the grounds that the bin was unstably stored.
Home Depot motioned the trial court for summary judgment, claiming that Hughes could not prove he did not cause the bin to fall upon himself and that he lacked evidence to show Home Depot was negligent or caused the injury he received. To show their purported innocence, Home Depot called in a twelve-year employee of the company, who testified that in all of his time there he had never heard of or seen an incident report where a product had fallen from a shelf.
The trial court sided with Home Depot, granting the summary judgment and later signing a dismissal of all of Hughes' claims with prejudice, meaning that his lawsuit was permanently over. Hughes appealed on the grounds that the trial court erred in granting the motion for summary judgment.
Summary judgments are appropriate when there are no genuine issues of material fact, and that the mover of the motion is entitled to judgment as a matter of law. LSA-C.C.P. art. 966(A)(3). Here, Home Depot just needed to show that Hughes could not prove one or more requirements of his claim.
Under Louisiana law, merchants have a duty to protect customers from merchandise which could fall from shelves as well as other hazardous conditions. See Smith v. Toys "R" Us, Inc., 754 So. 2d 209, 215 (La. 1999). This duty also means employees must check and maintain that the merchandise on the store shelves are in a safe position. To succeed in a "falling merchandise case," a customer must show that he or another customer did not cause the merchandise to fall on himself and that it was the store's negligence which caused the accident to occur. Proof of these requirements demonstrates an "unreasonably dangerous" condition and allows the store to be liable for the accident. Davis v. Wal-Mart Stores, Inc., 774 So.2d 84, 90 (La. 2000).
On appeal, Hughes stated that the trial court did not say what issues it granted the summary judgment motion on. The First Circuit Court of Appeal found no merit in Hughes' claim, as Home Depot's motion contained a memorandum which specifically addressed the issues it was seeking summary judgment on. Hughes also asserted that the trial court prematurely granted the motion because he had not yet had the chance to depose a Home Depot corporate representative. The Court found this erroneous as well, given that it had been nineteen months since the accident.
Hughes' final claim on appeal was that there was a genuine issue of material fact as to whether the bin's shelf placement was an unreasonable risk of harm. The Court dismissed this as well because even if this was true, Hughes' mere speculation was not enough, and he failed to provide affirmative proof that Home Depot's negligence caused the bin to fall on him. Because he could not meet all required elements of the claim, the Court affirmed the trial court's decision.
Hughes' case shows that process and proof make a huge difference in surviving a summary judgment motion. Good attorneys who have experience in the personal injury field of law know this, and can help injured customers, such as Darry Hughes, navigate the complicated legal intricacies required to bring a successful lawsuit.


A group from Venezuela has asked for training in ICDP.
The very first steps for the introduction of ICDP in Caracas were made in the second half of 2017, when Trina Frometa, a Venezuelan living in USA, started to work with Nicoletta Armstrong. She then received training in the basics of ICDP to enable her to present the main ideas of the ICDP programme to other interested parties.
Trina is an award winning Venezuelan choreographer who has worldwide recognition through over 50 acclaimed international choreographic presentations. In 1995 she founded the Contemporary Dance Company "Proyecto Movimientos" and has been working as the artistic director ever since. In USA she has been using dance therapy in relation to Parkinson's disease sufferers. For months now, Trina has been actively seeking and successfully obtaining support for families and children in Venezuela at a time of great need in that country, but more recently she has assumed the role of an ICDP ambassador - in the sense that she is trying to take the ICDP programme to her country.
Upon her temporary return to Caracas in April 2018, Trina will present the main content of the ICDP programme to a group of professionals who expressed interest to become ICDP trained. Afterwards, ICDP would organize a more systematic training processes for those who definitely commit to the entire ICDP training process.


text:
Q: WebDriverException: Message: unknown error: unrecognized Chrome version: HeadlessChrome RobotFramework I am trying to use google-chrome headless feature in my ubuntu machine to run selenium scripts headless .Following is the script that I am running
headless.robot
  *** Settings ***
    Documentation     This example demonstrates how to use current library
    Library      Selenium2Library

    *** Test cases ***
   Open Browser with Chrome options in headless mode
        ${options}  Evaluate  sys.modules['selenium.webdriver'].ChromeOptions()  sys, selenium.webdriver
        Call Method  ${options}  add_argument  --start-maximized
        Call Method  ${options}  add_argument  --headless
        Call Method  ${options}  add_argument  --disable-gpu
        #Call Method  ${options}  add_argument  --remote-debugging-port=${9222}
        Create WebDriver  Chrome    chrome_options=${options}
        Go To    https://www.google.com
        ${title}=    Get Title
        Log to console    ${title}

pybot headless.robot
==============================================================================
Headless :: This example demonstrates how to use current library
==============================================================================
[ WARN ] Keyword 'Capture Page Screenshot' could not be run on failure: No browser is open
Open Browser with Chrome options for configuring data source          | FAIL |
WebDriverException: Message: unknown error: unrecognized Chrome version: HeadlessChrome/59.0.3071.86
  (Driver info: chromedriver=2.26.436382 (70eb799287ce4c2208441fc057053a5b07ceabac),platform=Linux 3.13.0-119-generic x86_64)
------------------------------------------------------------------------------
Headless :: This example demonstrates how to use current library      | FAIL |
1 critical test, 0 passed, 1 failed
1 test total, 0 passed, 1 failed
==============================================================================
Output:  /var/robot-tests/output.xml
Log:     /var/robot-tests/log.html
Report:  /var/robot-tests/report.html

chromedriver --version
ChromeDriver 2.26.436382 (70eb799287ce4c2208441fc057053a5b07ceabac)
google-chrome --version
Google Chrome 59.0.3071.86
Dependency modules installed
apt-get install -y xvfb fluxbox x11vnc dbus libasound2 libqt4-dbus libqt4-network libqtcore4 libqtgui4 libxss1 libpython2.7 libqt4-xml libaudio2 fontconfig liblcms1 lib32stdc++6 libc6-i386 lib32gcc1 nano

A: Upgrade the chromedriver to the latest - currently v2.30; this issue should be fixed in v2.29 (and yours is older).
Also, according to the doc you need to uncomment the remote_debugging_port argument.
Btw, unrelated, the variable is called ${options}, but you are passing in desired_capabilities ${preferences} - a copy and paste error?


text:
Q: How to animate div for a fixed (offset) position using jQuery? I have a simple DIV that I would like to move (animate) to a known position on the screen ("fixed"). I have found that animate() method in jQuery moves the element in the given pixels but this is not what I'm looking for. Example:

My DIV's name is "frameArea" and I would like to move it to offset top: 5px / left: 260px. If I write the following, It will move the DIV  5px down and 260px to the right. What am I doing wrong? Is it possible?
 $("#frameArea")
       .animate({
           left: 260px,
           top: 5px
        }, 5000);

I'm new to HTML and jQuery, so please be gentle :)
Thanks!

A: Your code of top: 5px and left: 260px is saying where to begin the element. The starting point is 5px from the top and 260px from the left.
If you want the element to appear -5px (so 5px is cut off by the top of the browser window) type:
top: -5px;

A: Try this example. Make sure u start the animation after the element is loaded. May be in document.ready
Example


In July the Health Resources and Services Administration (HRSA) awarded the Granite County Medical Center a Network Planning Grant for the 2018-19 fiscal year. Under this grant the "Healthy Granite County Network" is being formed.
Kayla Sanders has been hired as the Project Director for this year-long process. "I am proud to be part of this process. As a member of the Granite County community, I am very excited about the potential improvements this could bring to us," Sanders said.
The goal of this network is to bring together a group of health care, public health, community and education stakeholders to collaborate on a plan to improve Granite County's healthcare services. Together, the network participants will work to create a realistic health improvement plan with identified projects, funding goals and timelines for completion.
There will be opportunities for community feedback throughout the planning process. Focus groups, surveys and community forums will be planned for the coming year. County wide collaboration is an integral part of the strategic planning process.
At fiscal year end, the resulting plan will be brought forward in an application to HRSA in an effort to receive a Rural Health Network Development grant. This larger, three-year grant would make it possible to put the network's plan in place.
Kayla Sanders can be reached by E-Mail at: kayla.sanders@granitecmc.org.


Fresh Machli is a fish farming company located in Jamshedpur (TATA), Jharkhand, India. We operate hatchery farm with 84 hectares of water surface for fresh water fish.
In conjunction with another our company, we also operate to farm ornamental fishes with latest technologies.
These guys delivered excellent fresh fishes, its like i personally went and caught.
Services are up to mark, recommend others to try them once. Fresh Machli guys are very promising.